Gloshell
Ingredients

Ingredient Dictionary

DODECENE

1-dodecene is an alkene that is dodecane containing one double bond at position 1.

Molecular structure

Definition

1-dodecene is an alkene that is dodecane containing one double bond at position 1. It is an intermediate used in the production of lubricants and surfactants. It has a role as a mammalian metabolite and a human metabolite. It is a volatile organic compound and a dodecene.

Source: PubChem

US FDA substance register · UNII WYE669F3GR · registered name 1-Dodecene · single chemical substance

Source: US FDA Unique Ingredient Identifier (UNII)

Cosmetic roles

Base that dissolves other ingredientsSOLVENTAdjusts thicknessVISCOSITY CONTROLLINGListed as a fragrance-composition material (not a claim that it adds scent)FRAGRANCE

Safety & regulatory references

Not classified under Korea’s toxic-substance GHS list · existing chemical substance

Source: Korea toxic substances GHS register (NIER)

More data — names, identifiers, properties, test records, literature

Official labels & definitions

JCIA labelling name ドデセン: 本品は、次の化学式で表される不飽和炭化水素である。

Source: JCIA labelling names (Japan)

Names & identifiers

DODECENEINCI도데센Korean label name (MFDS standard)1-DodeceneSynonymドデセンJapanese labelling name
CAS No.chemical registry number
112-41-4
EC No.EU chemical inventory number
203-968-4
DTXSIDUS EPA chemical ID
DTXSID5026914
DTXCIDUS EPA compound ID
DTXCID306914
IUPAC
Dodec-1-ene
Molecular formula
C12H24
Molecular weight
168.324 g/mol

Measured properties

Appearance
1-dodecene appears as a clear colorless liquid with a mild, pleasnat odor. Insoluble in water and floats on water. Harmful or fatal by ingestion. Inhalation of vapors may irritate and damage lungs. High concentrations may have a narcotic effect. · Liquid, CBI
Odour
MILD, PLEASANT
Boiling point
415 °F at 760 mmHg (USCG, 1999) · 213.8 °C
Melting point
-31 °F (USCG, 1999) · -35.2 °C
Solubility
Insoluble in water, sol in ethanol, ethyl ether, and acetone · Solubility in water: none
Density
0.758 at 68 °F (USCG, 1999) - Less dense than water, will float · 0.7584 g/cu cm @ 20 °C
Viscosity
1.72 sq mm/s @ 20 °C · 1.72 ㎟/s
Colour
colourless
Melting/freezing point
-36~-31 ℃
Initial boiling point and range
208~216 ℃
Flash point
77 ℃((c.c.))
Upper/lower flammability or explosive limits
0.62 / 5.42 %
Vapour pressure
0.159 ㎜Hg ( (25 ℃))
Vapour density
5.8-5.81
Relative density
0.7584-0.76
n-Octanol/water partition coefficient (Kow)
6.10
Auto-ignition temperature
225 ℃
Molecular weight
168.31

Values measured on the substance itself. The KOSHA data are a reference for writing and reviewing safety data sheets, not a specification for a commercial raw material.

Source: PubChem · KOSHA safety data sheets (Korea)

What products actually use it for

What the 23 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

  • Lubricating agent3
  • Viscosity modifier3
  • Deodorizer2
  • Processing aids not otherwise specified2
  • Chemical reaction regulator2
  • Intermediate2
  • Monomers1
  • Diluent1
7 other uses
  • Solvent1
  • Degradant/impurity (EPA)1
  • Surfactant (surface active agent)1
  • Fuel1
  • Elasticizer1
  • Defoamer1
  • Flavouring and nutrient1

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

18 skin studies and 7 eye studies are on record.

Classed as highly irritating5Classed as moderate3Classed as low30

The studies disagree (the most common conclusion covers 13%), so they do not establish that this ingredient is irritating. These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 25 studies
  • Moderate or Mild Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to other guideline: 16 CFR 1500.41 according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substance Labelling Act (FHSLA) according to
  • Severe Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: Magnusson and Kligman
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: U.S. EPA FIFRA (Pesticide Assessment Guidelines Subdivision F/TSCA (798.4470) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Severe Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act (FHSLA) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
  • Category 2
    Skin Irritation · Screening
  • Classification not possible
    Skin Sensitization · Screening
  • Moderate or Mild Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
  • Category 6.3A (Category 2)
    Skin Irritation · Read Across
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: Federal Register 28 (110), 6.6.1963. paragraph 191.12 Test for eye irritants. according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
  • Not classified
    Eye Irritation · Screening

Source: US EPA CompTox dashboard

Related literature

Linked databases 20